Sign up to save your podcasts
Or
Share JAMA Oncology : High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.
More shows like JAMA Network
View all
JAMA Editors' Summary
135 Listeners
Neurology® Podcast
290 Listeners
JAMA Author Interviews
164 Listeners
Diabetes Core Update
107 Listeners
JAMA Clinical Reviews
497 Listeners
EM Clerkship
809 Listeners
Mayo Clinic Talks
278 Listeners
The Curbsiders Internal Medicine Podcast
3,316 Listeners
JAMA Dermatology Author Interviews
17 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Psychiatry Author Interviews
22 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,103 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
195 Listeners
Psychopharmacology and Psychiatry Updates
289 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
365 Listeners
AMA Update
96 Listeners